178 related articles for article (PubMed ID: 6655279)
1. [Chromosomal analysis of primary superficial tumors of the bladder].
Martorana G; Giberti C; de Ferrari M; Ottaggio L; Giuliani L
J Urol (Paris); 1983; 89(7):489-92. PubMed ID: 6655279
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic analysis of transitional cell carcinoma of the bladder. Clinical implications.
Martorana G; Giberti C; de Ferrari M; Calvi P; Ottaggio L; Pescatore D
Eur Urol; 1983; 9(1):28-31. PubMed ID: 6822239
[TBL] [Abstract][Full Text] [Related]
3. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
[TBL] [Abstract][Full Text] [Related]
4. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
Panani AD; Ferti AD; Raptis SA; Roussos C
Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
[TBL] [Abstract][Full Text] [Related]
5. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
6. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology.
Babu VR; Lutz MD; Miles BJ; Farah RN; Weiss L; Van Dyke DL
Cancer Res; 1987 Dec; 47(24 Pt 1):6800-5. PubMed ID: 3479251
[TBL] [Abstract][Full Text] [Related]
7. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma.
Höglund M; Säll T; Heim S; Mitelman F; Mandahl N; Fadl-Elmula I
Cancer Res; 2001 Nov; 61(22):8241-6. PubMed ID: 11719456
[TBL] [Abstract][Full Text] [Related]
8. C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results.
Leonardo C; Merola R; Orlandi G; Leonardo F; Rondoni M; De Nunzio C
J Exp Clin Cancer Res; 2005 Dec; 24(4):633-8. PubMed ID: 16471327
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities detected in metaphase chromosomes in bladder carcinoma: prognostic value and comparison with histopathological factors.
Oosterhuis JW; Smeets AW; Janssen-Heijnen ML; Schapers RF; Pauwels RP; Newling DW
Virchows Arch; 2002 Aug; 441(2):187-93. PubMed ID: 12189510
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal and cell kinetic pattern in human transitional cell bladder carcinoma.
Silvestrini R; Costa A; Lavezzi AM; Matturri L
Basic Appl Histochem; 1987; 31(2):191-7. PubMed ID: 3632564
[TBL] [Abstract][Full Text] [Related]
11. [Cytogenetic analysis of transitional cell carcinoma of the bladder, stage B (pT2-3a/pN0)].
Angulo JC; López JI; Sanchez-Chapado M
Actas Urol Esp; 1994 Jun; 18(6):651-5. PubMed ID: 7942216
[TBL] [Abstract][Full Text] [Related]
12. Fifty-three month persistence of ring chromosome in noninvasive bladder carcinoma.
Falor WH; Ward RM
Acta Cytol; 1976; 20(3):272-5. PubMed ID: 1064279
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
14. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
Nenning H; Rassler J; Minh DH; Stolzenburg JU
Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
Khaled HM; Aly MS; Mokhtar N
Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
[TBL] [Abstract][Full Text] [Related]
16. [Low-grade and low-stage transitional carcinoma of the bladder. Review].
Escudero Barrilero A; Gutiérrez Sanz Gadea C; Hernández Fernández C; Romero Maroto J; Tallada Buñuel M; Perales Cabanas L
Actas Urol Esp; 1985; 9(3):203-8. PubMed ID: 3898736
[No Abstract] [Full Text] [Related]
17. Microsatellite instability as prognostic marker in bladder tumors: a clinical significance.
Vaish M; Mandhani A; Mittal RD; Mittal B
BMC Urol; 2005 Jan; 5():2. PubMed ID: 15647110
[TBL] [Abstract][Full Text] [Related]
18. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder.
Krüger S; Mess F; Böhle A; Feller AC
Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774
[TBL] [Abstract][Full Text] [Related]
19. Molecular cytogenetic characterization and diagnostics of bladder cancer.
Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
[TBL] [Abstract][Full Text] [Related]
20. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]